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disease is one of the most important medical tasks worldwide. Carotid artery intima-media thick-
ness (CIMT) is a marker of atherosclerosis, which has been associated with CV events. We exam-
ined the associations of a panel of different clinical, laboratory, and ultrasound variables
simultaneously and individually with CIMT; to reveal the presence of additional surrogate markers
of atherosclerosis to CIMT.
Subjects andmethods: 407 Consecutive non-diabetic individuals (220 men) who underwent compre-
hensive CV evaluation were included. The maximum IMT of the common and internal carotid
artery on the right and left side of the neck were recorded by ultrasonography, and CIMT was cal-
culated as the average of the four measurements. Ten-year Reynolds risk score (RRS) for CV events
was calculated online for men and women. CAVI was measured using a VaSera vascular screening
system, and the averages of the right and left CAVI were used for analysis after being adjusted for
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138 M.M. Ramadan et al.Results: Univariate linear regression models were constructed to test the association of each of the
independent variables with the log-transformed CIMT values [Ln (average CIMT) + 2] separately
for men and women. Only the variables with non-adjusted p 6 0.1 were included in the ﬁnal mul-
tivariately-adjusted stepwise linear regression model. After multivariate adjustment, only two vari-
ables were signiﬁcantly and independently associated with log-transformed CIMT values in males
(the log-transformed Reynolds risk score and the average age-matched CAVI) and females (the
average age-matched CAVI and systolic blood pressure).
Conclusion: RRS could be a candidate marker of atherosclerosis in men but not in women, while
age-adjusted CAVI could be considered a marker of atherosclerosis in both genders.
ª 2011 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Appropriate assessment and prevention of cardiovascular
(CV) disease is one of the most important medical tasks world-
wide. Because atherosclerosis is a major contributor to CV dis-
eases, accounting for a high percentage of mortality and
morbidity,1 the establishment of effective and accurate strate-
gies for screening is very important; as risk factor assessment
guides the therapeutic strategy.2 Therefore, as discussed by
the American Heart Association’s (AHA) Prevention V Con-
ference3, diagnostic tools capable of improving CV risk assess-
ment beyond known risk factors are needed. One such tool is
B-mode ultrasound, a noninvasive, simple, and generally
reproducible method to quantify carotid intima-media thick-
ness (CIMT).4
Carotid artery stenosis and carotid intima-media thickness
(CIMT) are markers of atherosclerosis, and have been associ-
ated with CV events including stroke and myocardial infarc-
tion (MI).5 While the degree of atherosclerosis in the
coronary artery is almost precisely evaluated by the invasive
coronary angiography (CAG), the noninvasive diagnosis of
carotid atherosclerosis by high-resolution B-mode ultrasonog-
raphy has been reported to be an independent predictor of cor-
onary heart disease.5,6
We hypothesized that atherosclerosis is a local and a systemic
process, and that different variables would be related to carotid
atheroscleroticmeasures. To test these hypotheses, we examined
the associations of a panel of different clinical, laboratory, and
ultrasound variables simultaneously and individually with mea-
sures of carotid atherosclerosis (CIMT) in a group of non-dia-
betic subjects who underwent comprehensive health
evaluation.We tried to reveal the presence of potential surrogate
markers of atherosclerosis, besides CIMT, which may help in
the noninvasive evaluation of atherosclerosis. Of particular
interest, we sought to understand the relationship of a speciﬁc
risk algorithm (Reynolds Risk Score) – which combines differ-
ent selected risk factors – with carotid atherosclerosis.2. Subjects and methods
2.1. Study design and participants
A total of 407 consecutive non-diabetic individuals (220 men)
who underwent comprehensive CV evaluation in the outpa-
tient clinic of Mansoura University Hospital, Mansoura Med-
icine Specialized Hospital, and Al-Fouad Cardiac and
Laboratory Center within the period from October 2008 to
April 2010 were included in this study.2.2. Data collection and laboratory measurements
We reviewed the medical history, general physical and neuro-
logical examination ﬁndings, and laboratory test results of
each patient. The following risk factors were considered: (1)
hypertension, deﬁned as having received anti-hypertensive
medication or having blood pressure (BP) >140/90 mm Hg
on repeated measurements 1 week after stroke onset; (2) cur-
rent cigarette smoking; which is deﬁned as any cigarette smok-
ing during the previous year; (3) hypercholesterolemia, deﬁned
as taking a cholesterol-reducing agent or a fasting cholesterol
level of >220 mg/dl (5.69 mmol/l); (4) history of CAD, deﬁned
as documentation of medication and history of MI, angina
pectoris, and/or previous coronary intervention conﬁrmed by
reviewing the medical records. Clinical characteristics of the
patients included in this study are shown in Table 1.
Waist circumference, height, and weight were measured;
and body mass index (BMI: kg/m2) was calculated. Systolic
and diastolic BP were recorded at rest, simultaneously with
the measurement of cardio-ankle vascular index (CAVI).
Standard 12-lead electrocardiograms (ECGs) were recorded
to evaluate the presence of left ventricular hypertrophy (LVH),
which was diagnosed as Cornell voltage duration product >2,
440 mV/ms. Additionally, 2-dimensional echocardiographic
examination was performed and the left ventricular mass (g)
was calculated according to the method recommended by the
American Society of Echocardiography [LV mass = 0.8 (1.04
[LVDd + IVST + PWT]3  LVDd3) + 0.6, where LVDd =
left ventricular diastolic dimension (mm), IVST = interven-
tricular septum thickness (mm), and PWT= posterior wall
thickness (mm)] followed by indexing to body surface area
(m2).
Blood samples were collected from each participant in the
morning after 12 h overnight fast. Serum and plasma were sep-
arated within 1 h and stored at 20 and 80 C, respectively,
until assay. Serum concentrations of total cholesterol (TC), tri-
glycerides (TG), low-density lipoprotein-cholesterol (LDL-C),
and high-density lipoprotein-cholesterol (HDL-C) were mea-
sured by standard laboratory procedures. Hemoglobin (Hb)
A1c was measured by high pressure liquid chromatography
with the Hi-Auto A1c kit. In addition to fasting blood sugar,
uric acid and serum creatinine were measured with an auto-
matic analyzer.
2.3. Carotid intima-media thickness measurement
The maximum IMTs of the common and internal carotid ar-
tery on the right and left side of the neck were recorded by
ultrasonography for males and females, with all subjects exam-
Table 1 Clinical characteristics of the study population.
Variable Total (n= 407) Males (n= 220) Females (n= 187) p-value
Hypertension 102 (25.1%) 54 (24.5%) 48 (25.7%) 0.884
Smoking
Current smokers 52 (12.8%) 37 (16.8%) 15 (8.0%) <0.001**
Ex-smokers 113 (27.8%) 89 (40.5%) 24 (12.8%)
Non-smokers 242 (59.5%) 94 (42.7%) 148 (79.1%)
Dyslipidemia 47 (11.5%) 20 (9.1%) 27 (14.4%) 0.127
Family history of IHD 16 (3.9%) 3 (1.4%) 13 (7.0%) 0.008**
IHD (angina and MI) 7 (1.7%) 2 (0.9%) 5 (2.7%) 0.326
Arrhythmias 13 (3.2%) 10 (4.5%) 3 (1.6%) 0.126
LVH on ECG 20 (4.9%) 12 (5.5%) 8 (4.3%) 0.743
Cerebral stroke 8 (2.0%) 4 (1.8%) 4 (2.1%) 0.816
Data are represented as number of patients (%).
ECG: electrocardiography; IHD: ischemic heart disease; LVH: left ventricular hypertrophy; MI: myocardial infarction.
** p< 0.01.
Gender-speciﬁc association between carotid intima-media thickness and Reynolds risk score 139ined in the supine position. A detailed protocol has been de-
scribed elsewhere.7 Both the carotid arteries were scanned lon-
gitudinally to visualize the IMT in the far wall of the artery.
Electrocardiogram-gated (R-wave) measurements were taken
in two sites: the common carotid and the internal carotid of
both carotid arteries. Then, the average CIMT used as the out-
come variable of interest in this study was calculated as the
average of the four measurements.8 The CIMT was deﬁned
as the distance between the characteristic echoes from the lu-
men-intima and media-adventitia interfaces.9 End-diastolic
images were digitized and a semi-automated edge detection
software program was used to identify leading-edge echo inter-
face points from the far wall of the distal 1 cm of the common
carotid artery.10
2.4. Calculation of Reynolds risk score
RRS was calculated online for men and women, using a user-
friendly calculator freely accessed at http://www.reynoldsrisk-
score.org. Beyond computation of 10-year risk, this web site
also includes patient-centered data on lifetime risk and pro-
vides estimates of risk reductions that can be anticipated with
the implementation of lifestyle change, smoking cessation, and
BP control.
2.5. Measurement of CAVI
CAVI was measured while the participant was resting in a su-
pine position, with monitoring of the electrocardiogram and
phonocardiogram. The principles underlying CAVI have been
described by Yambe et al.,11 and CAVI was determined using
the following equation: CAVI = a{(2q/DP) · ln (Ps/
Pd) · PWV2} + b, where Ps and Pd are the systolic and dia-
stolic BP, respectively; PWV is the pulse wave velocity between
the heart and ankle; DP is Ps  Pd; q is blood density; and a
and b are constants. All measurements and calculations were
made automatically using a VaSera VS-1000 vascular screen-
ing system (Fukuda Denshi, Tokyo, Japan).12–14 ECG elec-
trodes were placed on both wrists, a microphone for
detecting heart sounds is placed on the sternum, and cuffs
wrapped around all arms and ankles. After automatic mea-
surements, obtained data were analyzed using VSS-10 software
(Fukuda Denshi), and the values of right and left CAVI werecalculated. Averages of the right and left CAVI were used for
analysis after adjusting for age.
2.6. Statistical analyses
All analyses were performed with SPSS for Windows version
15 (SPSS Inc., IL). The normality of distribution values of dif-
ferent variables was checked by 1-sample Kolmogorov-Smir-
nov test. The association between CIMT and each of the
studied variables was tested by linear regression. Owing to
the skewed distribution of their values, this method required
the normalization of the outcome variable (CIMT) as well as
some of the input (regressor) variables. Thus, the average
CIMT values were normalized by natural log transformation;
with the addition of 2 to neutralize the negative sign resulting
from some values after transformation, so that the ﬁnal trans-
formation equation was Ln (average CIMT) + 2. Transforma-
tion of some skewed regressors was also done by different
methods and equations; which are shown in Tables 2 and 3
for males and females, respectively.
Multiple linear regression analysis was performed to evalu-
ate CIMT and other existing parameters adjusted for con-
founding factors, which showed signiﬁcant correlations with
CIMT by simple linear regression analysis in all subjects.
Although age also showed a signiﬁcant correlation with
CIMT, it was not analyzed as a confounding factor, because
of intercorrelation with average CAVI (r= 0.80, p< 0.01).
Therefore, we included both variables in a single representative
one: age-adjusted average CAVI.
2.7. Ethical approval
All patients gave informed consent to participate in this study.
3. Results
This study included 407 individuals (220 males, 54%), the
average age was 60.6 ± 12.3 years, without signiﬁcant mean
difference between males and females (59.5 ± 12.7 for men
vs. 61.7 ± 11.7 years for women; p= 0.072) though women
tend to be older.
As shown in Table 1, no gender predilection existed regard-
ing the distribution of various CV risk factors and disorders,
Table 2 Univariate linear regression models to test the association of each of the independent variables with the log-transformed
carotid intima-media thickness average values [Ln (average IMT) + 2] in 220 healthy men.
Variable Descriptive statistics Transformation R p-value
Age (y)# 59.5 ± 12.7 – 0.583 <0.001***
Reynolds risk score (RRS) 6.0 (3.0–10.0) Ln (RRS + 2) 0.565 <0.001***
Height (cm) 167.9 ± 5.9 – 0.199 0.003***
Weight (Kg) 68.7 ± 11.1 – 0.089 0.187
Body mass index (Kg/m2) 24.3 ± 3.3 – 0.003 0.965
Waist circumference (cm) 86.9 ± 9.1 – 0.092 0.174
Systolic blood pressure (mmHg) 130 (121.0–143.0) Ln (SBP) 0.244 <0.001***
Diastolic blood pressure (mmHg) 82.9 ± 10.9 – 0.078 0.249
Pulse (beat/min) 73.9 ± 11.7 – 0.083 0.218
Red blood count (· 10 6/mm3) 468.7 ± 43.9 – 0.067 0.324
White cell count (· 103/mm3) 5.4 (4.5–6.3) Ln (WBC) 0.067 0.325
Hemoglobin (g/dL) 14.8 ± 1.2 – 0.038 0.575
Hematocrite (%) 44.1 ± 3.5 – 0.016 0.809
Mean corpuscular hemoglobin 31.6 ± 1.7 – 0.053 0.438
Mean corpuscular volume 94.2 ± 4.4 – 0.103 0.129
Mean corpuscular hemoglobin conc. 33.5 ± 0.8 – 0.085 0.210
Platelet count (·107/mm3) 23.3 ± 5.7 – 0.024 0.723
Total protein (tot.ptn) (g/dL) 7.0 (6.8–7.3) 1/Ln (tot.ptn) 0.028 0.678
Serum albumin (g/dL) 4.4 ± 0.3 – 0.179 0.008***
SGOT (AST) (U/L) 22.0 (18.0–27.0) Ln (SGOT) 0.126 0.063*
SGPT (ALT) (U/L) 22.0 (16.0–33.0) Ln (SGPT) 0.020 0.764
Gamma glutamyl transaminase (U/L) 34.5 (23.0–58.0) Ln (GGT) 0.002 0.975
Total bilirubin (tot.bil) (mg/dL) 0.9 (0.7–1.0) SQRT (tot.bil) 0.029 0.669
Alkaline phosphatase (Al-P) (U/L) 155.0 (132.3–185.8) Ln (Al-P) 0.147 0.029**
Lactate dehydrogenase (U/L) 180.0 (165.0–200.0) Ln (LDH) 0.202 0.003***
Blood urea nitrogen (mg/dL) 15.0 ± 4.2 – 0.165 0.014**
Serum creatinine (SCr) (mg/dL) 0.86 (0.77–0.97) Ln (SCr) + 1 0.089 0.190
Fasting blood glucose (FBG) (mg/dL) 100.5 (93.0–112.0) 1/SQRT (FBG/100) 0.083 0.223
Hemoglobin A1c 5.3 (5.0–5.6) 1/SQRT (HbA1c) 0.144 0.033**
Total cholesterol (mg/dL) 208.8 ± 33.7 – 0.017 0.800
HDL-C (mg/dL) 56.8 (47.9–69.3) Ln (HDL-C) 0.003 0.967
LDL-C (mg/dL) 125.5 ± 30.2 – 0.051 0.447
Triglycerides (TG) (mg/dL) 110.5 (78.3–152.2) Ln (TG) 0.011 0.867
C-reactive protein (CRP) (mg/L) 0.06 (0.03–0.13) 1/SQRT (CRP) 0.135 0.045**
Serum uric acid (mg/dL) 6.2 ± 1.4 – 0.053 0.437
Serum Na+ (mEq/L) 139.7 ± 1.9 – 0.052 0.445
Serum K+ (mEq/L) 4.2 (4.0–4.4) Ln (K+) 0.104 0.123
Serum Ca+2 (mg/dL) 8.9 ± 0.3 – 0.149 0.027**
Serum phosphorus (mg/dL) 3.3 (3.0–3.6) Ln (Phosphorus) 0.017 0.807
Brain natriuretic peptide 13.4 (7.1–24.6) Ln (BNP) 0.338 <0.001***
Lipoprotein-a (Lp-a) (mg/dL) 9.3 (5.0–15.6) Ln (Lp-a) 0.158 0.019***
Left atrial diameter (cm) 3.34 ± 0.4 – 0.105 0.131
Ejection fraction (%) 66.3 ± 6.7 – 0.087 0.189
LV mass index (g/m2) 56.9 ± 7.3 – 0.101 0.191
Average ankle-brachial index 1.13 ± 0.07 – 0.042 0.535
Average CAVI# 8.1 ± 1.3 – 0.442 <0.001***
Age-matched maximum CAVI§ 9.2 ± 0.9 – 0.553 <0.001***
Average age-matched CAVI– 8.4 ± 0.9 – 0.548 <0.001***
Average baPWV 72.7 (64.3–78.4) Ln (Av.baPWV) 0.050 0.458
MDRD creatinine clearance 98.3 ± 20.4 – 0.206 0.002***
baPWV: brachial-ankle pulse wave velocity; CAVI: cardio-ankle vascular index; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-
density lipoprotein cholesterol; LV: left ventricle; MDRD: modiﬁcation of diet in renal diseases; SGOT (AST): serum glutamic oxalacetic
transaminase (aspartate transaminase); SGPT (ALT): serum glutamic pyruvic transaminase (alanine transaminase).
§ Variables not included in the ﬁnal linear regression model because of marked collinearity.* p< 0.1.** p< 0.05.
*** p< 0.01.
# Highly correlated variable pairs excluded from the ﬁnal multivariate linear regression model and replaced by an interaction term for each
pair of variables (marked with ‘‘–’’ sign).
– The interaction term replacing each pair of highly correlated variables (marked with ‘‘#’’ sign).
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Table 3 Univariate linear regression models to test the association of each of the independent variables with the log-transformed
carotid intima-media thickness average values [Ln (average IMT) + 2] in 187 healthy women.
Variable Descriptive statistics Transformation R p-value
Age (y)#1 61.7 ± 11.7 – 0.539 <0.001***
Reynolds risk score (RRS) 1.0 (1.0–3.0) Ln (RRS+ 2) 0.445 <0.001***
Height (cm) 154.5 ± 5.9 – 0.334 <0.001***
Body weight (Kg) 52.3 (48.0–56.9) Ln (weight) 0.113 0.124
Body mass index (Kg/m2) 22.3 ± 3.1 – 0.061 0.409
Waist circumference (cm) 81.5 ± 9.7 – 0.194 0.008***
Systolic blood pressure (mmHg) 125.9 ± 19.2 – 0.426 <0.001***
Diastolic blood pressure (mmHg) 78.1 ± 10.9 – 0.244 0.001***
Pulse (beat/min) 74.0 ± 10.5 – 0.002 0.974
Red blood count (· 106/mm3) 427.3 ± 32.6 – 0.069 0.350
White cell count (· 103/mm3) 5.2 ± 1.3 – 0.125 0.087*
Hemoglobin (g/dL) 13.3 ± 0.97 – 0.125 0.089*
Hematocrite (%) 39.9 ± 2.7 – 0.096 0.192
Mean corpuscular hemoglobin#2 31.1 ± 1.8 – 0.262 <0.001***
Mean corpuscular volume#2 93.5 ± 4.9 – 0.246 0.001***
MCH ·MCV interaction–2 29.1 ± 3.0 (MCH ·MCV)/100 0.257 <0.001***
Mean corpuscular hemoglobin conc. 33.2 ± 0.9 – 0.106 0.150
Platelet count (·107/mm3) 24.8 ± 6.9 – 0.057 0.438
Total protein (g/dL) 7.1 ± 0.4 – 0.018 0.804
Serum albumin (g/dL) 4.3 ± 0.2 – 0.003 0.967
SGOT-AST#3 (U/L) 20.0 (18.0–23.0) Ln (SGOT) 0.202 0.006***
SGPT-ALT#3 (U/L) 16.0 (13.0–21.0) Ln (SGPT) 0.174 0.017**
SGOT · SGPT interaction–3 1.3 ± 0.7 Ln (SGPT · SGPT/100) 0.196 0.007***
Gamma glutamyl transaminase (U/L) 19.0 (14.0–27.0) Ln (GGT) 0.092 0.212
Total bilirubin (tot.bil) (mg/dL) 0.8 (0.7–1.0) SQRT (tot.bil) 0.075 0.305
Alkaline phosphatase (Al-P) (U/L) 163.0 (134.0–204.0) Ln (Al-P) 0.254 <0.001***
Lactate dehydrogenase (U/L) 196.6 ± 36.3 – 0.143 0.052*
Blood urea nitrogen 14.3 ± 3.5 – 0.410 <0.001***
Serum creatinine§ (SCr) (mg/dL) 0.65 (0.57–0.72) Ln (SCr) + 1 0.158 0.031**
Fasting blood glucose (FBG) (mg/dL)§ 95.0 (89.0–102.0) 1/SQRT (FBG/100) 0.217 0.003***
Hemoglobin A1c (mg/dL) 5.2 (5.0–5.4) 1/SQRT (HbA1c) 0.177 0.015**
Total cholesterol (mg/dL)#4 219.1 ± 34.6 – 0.158 0.031**
LDL-C (mg/dL)#4 126.2 ± 31.2 – 0.173 0.018**
LDL/total cholesterol ratio (%)–4 57.0 ± 7.5 – 0.174 0.017***
HDL-C (mg/dL) 74.1 ± 16.9 – 0.058 0.426
Triglycerides (TG) (mg/dL) 88.0 (62.0–124.0) Ln (TG) 0.109 0.137
C-reactive protein (CRP) (mg/dL) 0.05 (0.03–0.09) 1/SQRT (CRP) 0.106 0.150
Serum uric acid (mg/dL) 4.9 ± 1.1 – 0.247 0.001***
Serum Na+ (mEq/L) 140.0 ± 1.8 – 0.208 0.004***
Serum K+ (mEq/L) 4.2 (4.0–4.4) Ln (K+) 0.142 0.052**
Serum Ca+2 (mg/dL) 8.9 ± 0.34 – 0.107 0.146
Serum phosphorus (mg/dL) 3.7 (3.4–4.0) Ln (Phosphorus) 0.014 0.847
Brain naitriuretic peptide 21.5 (11.8–33.3) Ln (BNP) 0.317 <0.001***
Lipoprotein-a (Lp-a) (mg/dL) 13.7 (7.2–24.9) Ln (Lp-a) 0.069 0.351
Left atrial diameter (cm) 3.19 ± 0.3 – 0.109 0.128
Ejection fraction (%) 64.7 ± 5.9 – 0.097 0.175
LV mass index (g/m2) 52.8 ± 6.1 – 0.106 0.183
Average ankle-brachial index 1.1 ± 0.06 – 0.047 0.525
Average CAVI#1 7.9 ± 1.05 – 0.457 <0.001***
Age-matched maximum CAVI§ 9.3 ± 0.9 – 0.528 <0.001***
Average age-matched CAVI–1 8.5 ± 0.9 – 0.526 <0.001***
Average baPWV 72.5 (66.0–79.0) Ln (Av.baPWV) 0.321 <0.001***
MDRD creatinine clearance 100.9 ± 21.0 – 0.233 0.001***
Abbreviations as in Table 2.
§ Variables not included in the ﬁnal linear regression model because of marked collinearity.* p< 0.1.** p< 0.05.
*** p< 0.01.
# Highly correlated variable pairs excluded from the ﬁnal multivariate linear regression model and replaced by an interaction term for each
pair of variables (marked with ‘‘–’’ sign). The number next to the signs indicates the corresponding pair and interaction.
– The interaction term replacing each pair of highly correlated variables (marked with ‘‘#’’ sign). The number next to the signs indicates the
corresponding pair and interaction.
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142 M.M. Ramadan et al.apart from smoking status and CAD family history. The most
commonly found was hypertension, which prevailed in one
forth of men and women.
Increased CIMT (deﬁned as CIMT P1.0 mm) existed in
263 subjects (64.6%), 148 males (67.3%) and 115 females
(61.5%); without signiﬁcant gender predilection (p= 0.267).
The association between CIMT (represented as the log-trans-
formed CIMT average values [Ln (average CIMT) + 2]) and
dichotomous variables in this study (smoking, family history
of MI, and metabolic CV syndrome) did not prove statistically
signiﬁcant (Table 4).
Univariate linear regression models were constructed to test
the association of each of the independent (input) variables
with the log-transformed CIMT average values [Ln (average
CIMT) + 2] separately for men and women. Only the vari-
ables with non-adjusted p 6 0.1 were included in the ﬁnal mul-
tivariately-adjusted stepwise linear regression model. The
correlation matrix was checked carefully to correct for the col-
linearity issue, and the correction necessitated the exclusion of
some variables (associated with rP±0.7) from the ﬁnal mul-
tivariate linear regression model (the variables annotated with
‘‘§’’ sign in Tables 2 and 3). In the case of women, some highly
correlated variables were included in the ﬁnal stepwise linear
regression model as the interaction term (each pair of variables
annotated with ‘‘#’’ sign in Table 3 was replaced in the ﬁnal
stepwise linear regression model with the interaction term
annotated with ‘‘–’’ sign).
Finally, and after multivariate adjustment, only two vari-
ables were signiﬁcantly and independently associated with
log-transformed CIMT values in males; which are the log-
transformed Reynold’s risk score and the average age-matched
CAVI (Table 5). As for females, also two variables were signif-
icantly and independently associated with log-transformed
CIMT values; namely the average age-matched CAVI and sys-
tolic BP (Table 4).
4. Discussion
The noninvasive assessment of atherosclerosis is a challenging
task, and research institutes worldwide are making every effort
to employ efﬁcient modalities to achieve this goal, resulting in
the invention of such techniques as coronary artery computed
tomographic (CT) scanning, including the measurement of
coronary artery calcium (CAC) score, and CIMT measure-
ment by ultrasonography. However, the latter is invariably
easier than coronary CT, devoid of radiation exposure, and
of much lower cost; making it one of the best noninvasive
methods for evaluating atherosclerotic burden. Nevertheless,
its routine use for the evaluation of generalized atherosclerosis
is questionable, owing to the localized nature of the scanned
artery (only the carotids). For that reason, this study included
such novel measures of generalized atherosclerosis (such as
CAVI) as well as a validated scoring algorithm for CV risk pre-
diction (RRS) in a trial to discover the possible interrelation-
ships between CIMT and both these novel modalities. Such
association – when present – will enable us to use CAVI and
RRS as screening tests (besides CIMT) for the noninvasive
evaluation of atherosclerotic diseases. This study is the ﬁrst
to investigate the association between CIMT and RRS; and
it is one of the very few comprehensive researches studying
the relationship of CIMT with a big panel of biochemical
and other markers.
Table 5 Results of the ﬁnal stepwise multivariate linear regression model used to test the independent association of each of the
selected independent variables (with entry threshold of p 6 0.1) with the log-transformed carotid intima-media thickness average values
[Ln (average IMT) + 2] separately for males and females.
Variables b-Coeﬃcient 95% CI of b Coeﬃcient p-value Model’s R Model’s adjusted R2 Model’s p-value
Males 0.582 0.333 0.012**
Ln (RRS+ 2) 0.170 0.075–0.264 <0.001***
Average age-matched CAVI 0.080 0.018–0.143 0.012**
Females 0.594 0.346 <0.001***
Systolic blood pressure 0.005 0.003–0.007 <0.001***
Average age-matched CAVI 0.152 0.109–0.195 <0.001***
CAVI: cardio-ankle vascular index; RRS: Reynolds risk score.
** p<0.05.
*** p<0.01.
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This study demonstrates the independent association of RRS
and CIMT in men but not in women. Also, it shows the inde-
pendent association of CAVI with CIMT in both men and
women.
5.1. Carotid artery IMT
Carotid artery arteriosclerosis detected by carotid ultrasound
is known to be representative of the whole body. Measure-
ments of CIMT by high resolution B-mode carotid ultrasonog-
raphy have been widely used as a noninvasive method of
quantifying arterial wall thickening and atherosclerosis pro-
gression, and increased CIMT has been shown to correlate
with prevalent CV disease15,16 and with incident myocardial
infarction and stroke.15,17 In the available prospective studies,
internal and common carotid artery IMT predict increased risk
for myocardial infarction and stroke.17,18 In particular, it has
been reported that the carotid IMT is a marker of the presence
of severe symptomatic coronary artery disease.19 Furthermore,
increased common CIMT may be regarded as a valid marker
of generalized atherosclerosis because it is strongly associated
with atherosclerosis in other parts of the arterial system.20 It
is known that risk factors for carotid atherosclerosis are gener-
ally similar to those for CAD.21,22
The atherosclerotic process affects predominantly vessel
bifurcations, such as the carotid artery bifurcation and proximal
segment of the internal carotid artery. This ﬁnding is likely re-
lated to the fact that individual segments of the carotid artery
are differentially exposed to turbulent ﬂow, with higher shear
forces acting at the internal carotid and carotid bifurcation.23
Adaptive remodeling of the vessel wall in adjusting to altered lo-
cal mechanical stresses takes place to maintain normal values of
tensile stress. This remodeling involves intimal thickening,
which may strengthen the arterial wall, making CIMT an inter-
mediate and subclinical marker of atherosclerosis.245.2. CIMT and coronary calcium
Coronary artery calciﬁcation (CAC) measured by CT can
identify a high-risk group with silent myocardial ischemia
among an otherwise low-risk heterogeneous population with
cardiac risk factors.25 An important role of CT as a primary
screening tool for identifying individuals with various degrees
of subclinical CAD is postulated, particularly those at highrisk for short-term events in whom aggressive diagnosis and
therapy are advisable.25
The Rotterdam Coronary Calciﬁcation Study showed that
the common carotid artery wall thickness is signiﬁcantly asso-
ciated with CAC.26 Also, it was found that those with any
CAC had a higher mean maximal CIMT measured at 12 car-
otid artery locations (near and far wall measurements of the
internal carotid, common carotid, and carotid bifurcations)
in young men and women.27 In the same context, one study28
has demonstrated an association between CIMT and CAC
that supports the use of carotid ultrasound to identify young
adults at risk for premature atherosclerosis not only in the car-
otid arteries but also in the coronary arteries. Taken together,
these data signify the use of CIMT as a suitable alternative to
CAC screening by CT. Compared to CAC scoring, the use of
CIMT has many advantages; including the avoidance of radi-
ation exposure, simple technique, low cost, and saving of time.
5.3. The association between CIMT and CAVI
CAVI is a novel index which reﬂects the stiffness of the aorta,
femoral, and tibial arteries; and involves the measurement of
brachial-ankle PWV and BP.11,14 CAVI is essentially indepen-
dent of BP and has adequate reproducibility for clinical use.14
Several reports have shown the usefulness of CAVI for detect-
ing atherosclerotic diseases12–14, and it has been evaluated as a
screening tool for atherosclerosis in the general population.13
CAVI has been shown as independently associated with
CIMT in the general adult population29 but not in the young
adults (18–31 years).30 Recently, a signiﬁcant positive correla-
tion between CAVI and CIMT by simple linear regression anal-
ysis has been shown in hypertensive patients.31 As with baPWV,
the measurement of CAVI requires only a few minutes for the
entire procedure. Our results suggest that measurement of
CAVI in combination with CIMT might be appropriate for
screening of the individuals of both genders, giving reliable
information on clinical and subclinical atherosclerosis.
It is reported that atherosclerotic change of the aorta pre-
cedes that of the coronary, while carotid atherosclerosis fol-
lows coronary atherosclerosis.32 These reports might explain
the reason why CAVI is a more important indicator for dis-
criminating the probability of coronary atherosclerosis than
ﬁndings of carotid atherosclerosis by high-resolution B-mode
ultrasonography, because CAVI mainly reﬂects the atheroscle-
rotic change of aorta.33
In the Rotterdam study, arterial stiffness was strongly asso-
ciated with common CIMT.34 It seems that both are closely re-
144 M.M. Ramadan et al.lated, and are important as markers of stages of atherosclero-
sis. In the present study, CIMT was independently associated
with CAVI, a result which might suggest that CAVI reﬂects
systemic arterial sclerosis; whether carotid or coronary.
5.4. Reynolds risk score and CIMT
Reynolds risk score (www.reynoldsriskscore.org) is an im-
proved algorithm for the assessment of global CV risk that
added information on inﬂammation (high-sensitivity C-reac-
tive protein [hsCRP]) and genetic risk (parental history of
myocardial infarction before age of 60 years) to that on age,
BP, smoking history, TC, HDL-C was recently developed
and validated in a large prospective cohort of American wo-
men35 and men.36 Using RRS algorithm, it was observed that
approximately 30%35 and 20%36 of initially healthy women
and men (respectively) estimated to be at ‘‘intermediate risk’’
could be reclassiﬁed into higher- or lower-risk categories with
greatly improved accuracy.
In our study, we found that the correlations of CIMT and
each of the components of RRS were neither strong nor inde-
pendent; while RRS was fairly and independently associated
with CIMT in men but not in women (i.e. gender-speciﬁc asso-
ciation). Recently, it has been shown that the risk for CV dis-
ease in patients with metabolic syndrome is greater than that in
patients with classic risk factors alone.15 Similarly, the risk for
CV disease may be related to RRS rather than the individual
components of the RRS algorithm, as shown by our study of
male patients. This ﬁnding is supported by the view that multi-
ple risk factors have a synergistic effect on the risk for CV dis-
eases.37 However, RRS was not independently associated with
CIMT in women. We do not have deﬁnite reasons for this ﬁnd-
ing, but may be the lower values for RRS in women compared
to men were not empowered to predict increased CIMT values.
5.5. Clinical implications of our ﬁndings
Among non-invasive methods, the imaging studies using mul-
tidetector-row computed tomography and nuclear medicine
have good sensitivity for the detection of coronary atheroscle-
rosis. However, these methods imply more radiation exposure,
high cost, the need of special devices, large amount of space,
and special technicians. Consequently, few institutions are able
to perform these tests routinely. Our study suggests the use of
RRS and CAVI as useful tools for the screening of coronary
atherosclerosis, based on their fair and independent associa-
tion with CIMT. In fact, CAVI is a simple method that re-
quires no special technique, and it is possible for all
institutions to measure CAVI once its device is available; while
RRS is easily obtained with just measuring some routinely ob-
tained biochemical data together with simple history taking.
Thus, combining data from CIMT, CAVI, and RRS can give
valuable additional information about the noninvasive evalua-
tion of atherosclerosis.
6. Limitations
Our results may be viewed as ‘‘cross sectional’’ associations, in
particular because rates of CIMT progression in untreated
arms of randomized trials have been reported to be on the or-
der of 0.01 mm/year and are likely to be even slower in a gen-
eral community dwelling of men and women.It is sometimes difﬁcult to compare results regarding caro-
tid atherosclerosis among studies because of the differences in
the sites and methods of CIMT measurement, the deﬁnition of
atherosclerosis, and the demographics (age and ethnicity) of
the study population.
7. Conclusions
RRS could be a candidate marker of atherosclerosis in men
but not in women, while age-adjusted CAVI could be consid-
ered a marker of atherosclerosis in both genders. Combining
data from CIMT, CAVI, and RRS can give valuable addi-
tional information about the noninvasive evaluation of
atherosclerosis.
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